Lee Alan Johnson

Lee is a versatile intellectual property attorney and registered Patent Agent who advises clients on a broad spectrum of IP matters, from patent prosecution and portfolio management to disputes to IP strategy and diligence in connection with transactions. He represents clients across a variety of industries, including biotechnology, pharmaceuticals, medical devices, AgTech, and FoodTech, on both the company and investor side. Through his work in this space, Lee is an active member of the life sciences ecosystem and has developed strong relationships with venture capital funds, investors, strategic partners, universities, and other incubators.

In his multifaceted work for companies and IP innovators, Lee drafts and prosecutes US and international patents, develops patent strategies, and serves in an advisory role to clients facing disputes before courts in the United States and Canada, and the USPTO. Lee also acts on behalf of investors, emerging companies, and transactional IP counsel in licensing and technology transfer arrangements, research collaborations and partnerships, initial public offerings (IPOs), mergers, and acquisitions.

Lee regularly counsels clients at all stages of growth in order to secure funding, develop and protect their IP portfolios, create long-term strategies, and achieve desired business outcomes. He is often a company’s first lawyer and has deep experience working alongside founders to obtain funding, scale the business, and create profitable exit strategies.

Lee enjoys mentoring budding biotech entrepreneurs, and he frequently writes and speaks on how companies can access capital and maximize their assets. He has given guest lectures at the University of Toronto Medical School, CalTech, the Amplitude Fellowship program, and the University of British Columbia School of Biomedical Engineering.